longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Insulet

PODD

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 25.22, below the reasonable range, cheaper than 99.49% of the time in the past 3 years, and the industry ranks 24/175, the industry Median -0.85.

25.22xP/E
$136.49Stock price
$5.41Earnings per share
25.22xP/E
Stock price$136.49Earnings per share$5.41

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
56.14x
Typical range
41.44x–82.59x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
21.84x26.73%$114.23B
SYKUSStryker
28.12x53.09%$104.87B
BSXUSBoston Scientific
17.60x36.31%$64.66B
RMDUSResmed
21.05x11.93%$32.07B
GEHCUSGE HealthCare Tech
15.04x2.63%$29.85B
RYLPFUSKoninklijke Philips N.V.
17.97x--$23.24B
PHGUSKoninklijke Philips Elect
18.48x16.23%$23.90B
TRUMYUSTerumo
19.79x--$20.80B
STEUSSteris
25.43x17.10%$20.47B
ZBHUSZimmer Biomet
21.49x37.01%$17.33B
SNNUSSmith and Nephew
17.76x42.74%$11.28B
GMEDUSGlobus Medical Inc
18.55x6.02%$9.93B
PODDUSInsulet
25.22x76.42%$9.47B
SSMXYUSSysmex
28.06x--$7.10B
LIVNUSLivanova
22.55x189.82%$4.25B
TMDXUSTransMedics
19.89x71.90%$3.02B
LMATUSLemaitre Vascular
28.03x13.99%$1.84B
CNMDUSConmed
24.28x156.95%$1.37B
TCMDUSTactile
20.43x36.59%$508.09M
BWAYUSBrainsway
27.90x70.37%$263.42M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.